Prediction Case File
YouTubePartially Resolved

Should You Buy Salesforce Stock Instead of Oracle Stock? | CRM Stock Analysis | ORCL Stock Analysis

2 extracted signals · 1 resolved · 1 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFA06 Jul 2026, 12:45 UTC
Video preview for Should You Buy Salesforce Stock Instead of Oracle Stock? | CRM Stock Analysis | ORCL Stock Analysis
Signals
2
Eligible signals in this source
Open
1
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis compares Salesforce (CRM) and Oracle (ORCL) based on financial metrics. Both stocks have seen significant price declines, with CRM down 36.91% and ORCL down 28.03% year-to-date. Oracle's revenue growth is accelerating, reaching $67.36B in the trailing twelve months (TTM), while Salesforce's revenue growth is slowing, with $42.84B TTM. Oracle's operating margin (33.32% TTM) is higher and has been improving, whereas Salesforce's operating margin (21.87% TTM) saw a dip before recovering. Oracle's CAPEX to revenue ratio (0.826) is substantially higher than Salesforce's (0.013), indicating more aggressive capital expenditure, possibly for data centers supporting AI initiatives. Both companies are considered undervalued based on discounted cash flow models, with Salesforce's intrinsic value estimated at $290.44 and Oracle's at $219.42. Despite both trading at their cheapest valuations in years, Salesforce is presented as the better buy due to its cheaper valuation and perceived stronger positioning for AI integration. The analysis is based on fundamental financial data and a 1-day timeframe.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Live evaluation in progress

    1 signal remains active.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Parkev Tatevosian, CFA

Tracked signals
1097
Historical success
24.1%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.